Clover Health

Today's third quarter results demonstrate Clover's technology-powered differentiation and how earlier identification and management of chronic disease, strong growth, and increasing profitability can reinforce one another.

Some highlights:

$62M YTD GAAP Net Income

YTD average Medicare Advantage membership growth +49% YoY

Improved FY 2026 guidance

Flagship PPO received 5 Stars for Payment Year 2028

Read more: investors.cloverhealth.com/static-files/a…

Following yesterday’s earnings announcement, we’re pleased to recognize Clay Thornton’s appointment as Chief Financial Officer and Joe Oldakowski’s appointment as Chief Accounting Officer of Clover Health.

Both bring deep expertise and disciplined leadership to their roles. Congratulations!

We’re proud to be recognized among U.S. News & World Report's Best Medicare Advantage ratings for 2027 in New Jersey, Georgia, and South Carolina!

Clover earned the highest scores in Care Continuity in all 3 states.

Learn more: investors.cloverhealth.com/news-releases/…

Y0129_26EX091F1_C

Clover Health’s MA PPO plans received a 5-Star rating and its HMO plans received a 4.5-Star rating for 2027. We’re proud of what this means for our ability to continue delivering strong benefits, affordability and wide provider choice—while supporting reforms that better align Stars with meaningful improvements in members’ health.

For the third year in a row, Clover has continued its market-leading performance on core HEDISⓇ* measures with a score of 4.82 out of 5 Stars,** again ranking #1 among non-SNP PPO plans with over 2,000 members.

For the 2027 Star Ratings, Clover’s overall rating was driven by improvements across Stars domains. This performance reflects the strength of our care model, powered by @counterparthlth, which surfaces relevant information to help physicians identify care needs and support better-informed clinical decisions.

Read more: investors.cloverhealth.com/news-releases/…

* HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA)

** This analysis focuses on performance by non-SNP PPO plans with over 2,000 lives as of September 1, 2024, 2025, and 2026 on HEDIS measures applicable to non-SNPs that were used for CMS’s MY 2023, MY2024, and MY 2025 Star ratings, applying the measure ranges used by CMS.

Clover Health Q3 2026 earnings results are set for release after market on Wednesday, November 4, 2026.

Have a question for our leadership team? Our CLOV Supplemental Q&A submissions form is now open and we plan to publish responses the week following earnings.

Please submit all questions via our IR website anytime between now and 4:30pm ET on Wednesday, October 28th. We look forward to hearing from you!

Access our Q&A submissions form here: forms.gle/oq9WW7GtNwygDc…